SV2009003365A - Obtencion, aislamiento y crioconservacion de celulas endometriales/menstruales ref. p1879 - Google Patents
Obtencion, aislamiento y crioconservacion de celulas endometriales/menstruales ref. p1879Info
- Publication number
- SV2009003365A SV2009003365A SV2009003365A SV2009003365A SV2009003365A SV 2009003365 A SV2009003365 A SV 2009003365A SV 2009003365 A SV2009003365 A SV 2009003365A SV 2009003365 A SV2009003365 A SV 2009003365A SV 2009003365 A SV2009003365 A SV 2009003365A
- Authority
- SV
- El Salvador
- Prior art keywords
- english
- centuries
- mscs
- crioconservation
- endometrial
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
LA INVENCIÓN PROVEE COMPOSICIONES QUE COMPRENDEN CÉLULAS MADRE MENSTRUALES (MSCS (POR SUS SIGLAS EN INGLÉS), Y MÉTODOS, PROCESOS Y SISTEMA QUE LAS INVOLUCRA. LAS MSCS (POR SUS SIGLAS EN INGLÉS) SON PROCESADAS A PARTIR DEL FLUJO MENSTRUAL RECOGIDO DURANTE LA MENSTRUACIÓN. LAS MSCS (POR SUS SIGLAS EN INGLÉS) PUEDEN CRIOCONSERVARSE, PROCESARSE MEDIANTE VARIOS CULTIVOS Y PASOS DE SELECCIÓN PARA USO TERAPÉUTICO O COSMÉTICO. LAS MSCS (POR SUS SIGLAS EN INGLÉS) CRIOCONSERVADAS PUEDEN DESCONGELARSE PARA LA PREPARACIÓN DE PRODUCTOS PARA USO TERAPÉUTICO O COSMÉTICO. LAS MSCS (POR SUS SIGLAS EN INGLÉS) EXPRESAN CD9, CD10, CD13, CD29, CD44, CD49E, CD49F, CD59, CD81, CD105, CDL66, Y HLA CLASE I, Y TIENEN UNA BAJA O NULA EXPRESIÓN DE CD3 Y HLA CLASE II. ES TRADUCCIÓN FIEL AL IDIOMA NACIONAL DEL DOCUMENTO ADJUNTO EN IDIOMA INGLÉS QUE HE TENIDO A LA VISTA Y AL CUAL ME REMITO. BUENOS AIRES 13 DE MARZO DE 2008
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90483607P | 2007-03-01 | 2007-03-01 | |
US91896107P | 2007-03-20 | 2007-03-20 | |
US99416607P | 2007-09-17 | 2007-09-17 | |
US99825507P | 2007-10-09 | 2007-10-09 | |
US1188108P | 2008-01-22 | 2008-01-22 | |
US6784908P | 2008-02-29 | 2008-02-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2009003365A true SV2009003365A (es) | 2010-01-27 |
Family
ID=39738979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2009003365A SV2009003365A (es) | 2007-03-01 | 2009-09-01 | Obtencion, aislamiento y crioconservacion de celulas endometriales/menstruales ref. p1879 |
Country Status (17)
Country | Link |
---|---|
US (2) | US20080241113A1 (es) |
EP (2) | EP2132299A4 (es) |
JP (1) | JP2010530214A (es) |
KR (1) | KR20090117817A (es) |
CN (2) | CN102851254A (es) |
AR (1) | AR065584A1 (es) |
AU (1) | AU2008223426A1 (es) |
BR (1) | BRPI0807966A2 (es) |
CA (1) | CA2679834A1 (es) |
CR (1) | CR11006A (es) |
HN (1) | HN2009001681A (es) |
IL (1) | IL200620A0 (es) |
MX (1) | MX2009009414A (es) |
SG (1) | SG179432A1 (es) |
SV (1) | SV2009003365A (es) |
TW (1) | TW200902718A (es) |
WO (1) | WO2008109063A2 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009544362A (ja) | 2006-07-20 | 2009-12-17 | バート リチャード | 損傷を受けた組織の修復のための有糸分裂的に不活性化された幹細胞の使用方法 |
US20090053182A1 (en) * | 2007-05-25 | 2009-02-26 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
TW200918020A (en) * | 2007-09-14 | 2009-05-01 | Cryo Cell Int | Infectious disease testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples |
CA2714777A1 (en) * | 2007-10-31 | 2009-05-07 | Cryo-Cell International, Inc. | Methods for co-culturing cord blood derived cells with menstrual stem cells |
JP5280451B2 (ja) | 2007-11-30 | 2013-09-04 | アールエヌエル バイオ カンパニー リミテッド | 脱落膜由来幹細胞または脂肪由来幹細胞を含有する尿失禁の細胞治療剤 |
US8282612B1 (en) * | 2008-03-07 | 2012-10-09 | Denise H. Miller | Methods and devices for intrauterine absorption |
WO2010056988A2 (en) | 2008-11-13 | 2010-05-20 | University Of South Florida | Methods of treating stroke using stem cell-like menstrual blood cells |
WO2011109717A1 (en) * | 2010-03-04 | 2011-09-09 | Cryo-Cell International, Inc. | Methods and processes for collecting, preserving, and culturing adult stem cells obtained from lochia and related compositions of matter |
JP2013523774A (ja) * | 2010-04-01 | 2013-06-17 | クライオ−セル インターナショナル インコーポレイテッド | 創傷治癒を改善する細胞治療並びに関連する組成物及び方法 |
CN102154202A (zh) * | 2010-04-06 | 2011-08-17 | 杭州易文赛生物技术有限公司 | 储存宫内膜干细胞的方法 |
EP2624845A4 (en) | 2010-10-08 | 2015-09-09 | Mesoblast Internat S Rl | REINFORCED MSC PREPARATIONS |
US9574175B2 (en) * | 2011-09-06 | 2017-02-21 | Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | Endometrial polyp stem cell |
US9427450B2 (en) | 2012-01-31 | 2016-08-30 | Xon Cells, Inc. | Therapeutic immune modulation by stem cell secreted exosomes |
SG11201405875PA (en) | 2012-03-19 | 2014-11-27 | Richard Burt | Methods and compositions for regenerating and repairing damaged tissue using nonviable irradiated or lyophilized pluripotent stem cells |
US9078786B1 (en) | 2012-10-19 | 2015-07-14 | Denise H. Miller | Methods and devices for collecting body fluids |
WO2014135924A1 (en) | 2013-03-08 | 2014-09-12 | Cells For Cells | Menstrual stems cells for the efficient support and expansion of cd34+ cd133+ hematopoietic stem cells in vitro |
JP6512759B2 (ja) | 2013-08-19 | 2019-05-15 | 国立研究開発法人国立循環器病研究センター | 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤 |
EP3157537A1 (en) * | 2014-06-17 | 2017-04-26 | Cells For Cells S.A. | Menstrual blood-derived stem cells for the treatment of human pancreatic carcinoma |
CN107111688A (zh) * | 2015-01-20 | 2017-08-29 | 通用电气医疗集团生物科学公司 | 在细胞加工设施中的过程模拟 |
US10813955B2 (en) | 2015-09-29 | 2020-10-27 | Genani Corporation | Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells |
WO2019046494A1 (en) * | 2017-08-30 | 2019-03-07 | Dot Laboratories, Inc. | METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF ENDOMETRIOSIS |
US11315660B2 (en) | 2018-10-31 | 2022-04-26 | Dot Laboratories, Inc. | Method of detecting and treating endometriosis in a female subject |
KR102676517B1 (ko) * | 2021-07-08 | 2024-06-20 | 박정원 | 생리혈로부터 줄기세포를 수득하는 방법 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4325388A (en) * | 1973-02-05 | 1982-04-20 | Louis Bucalo | Apparatus for collecting and processing body fluids |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
US5426098A (en) * | 1993-09-02 | 1995-06-20 | Celtrix Pharmaceuticals, Inc. | Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
AU4336599A (en) * | 1998-06-08 | 1999-12-30 | Osiris Therapeutics, Inc. | (in vitro) maintenance of hematopoietic stem cells |
US6458589B1 (en) * | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
NL1017973C2 (nl) * | 2000-05-10 | 2002-11-08 | Tristem Trading Cyprus Ltd | Inrichting. |
US20020120243A1 (en) * | 2000-12-22 | 2002-08-29 | Robert Kraemer | Intravaginal device for feminine hygiene |
CA2433356A1 (en) * | 2001-01-02 | 2002-10-03 | Supachill International Pty. Ltd. | Method and system for preparing tissue samples for histological and pathological examination |
US20030012701A1 (en) * | 2001-07-13 | 2003-01-16 | Sangha Jangbir S. | Insulated specimen sampling and shipping kit |
CN1281739C (zh) * | 2002-02-19 | 2006-10-25 | 美迪宝斯特有限公司 | 从脐带血中分离并扩大培养间充质干细胞/祖细胞及将脐带血来源的间充质干细胞/祖细胞分化成各种间充质组织的方法 |
US8334135B2 (en) * | 2002-07-31 | 2012-12-18 | Yves Saint Laurent Parfums | Stem cells from adipose tissue, and differentiated cells from said cells |
JP2006505380A (ja) * | 2002-11-05 | 2006-02-16 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | 間葉幹細胞およびその使用方法 |
JP5148873B2 (ja) * | 2003-06-27 | 2013-02-20 | エチコン、インコーポレイテッド | 臍帯組織由来の分娩後細胞、及びその作成及び使用方法 |
JP3968383B2 (ja) * | 2004-09-01 | 2007-08-29 | 株式会社日本メディカル総研 | 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防 |
US7803920B2 (en) * | 2004-09-29 | 2010-09-28 | Shinya Yamanaka | ECAT16 gene expressed specifically in ES cells and utilization of the same |
FR2876701B1 (fr) * | 2004-10-15 | 2010-09-17 | Genevrier Lab | Procede de preparation d'un systeme de culture d'endometre autologue pour la co-culture endometre-embryon |
JP2006204292A (ja) * | 2004-12-27 | 2006-08-10 | Asahi Kasei Corp | ヒト胚性幹細胞分化抑制剤 |
WO2006078034A1 (ja) * | 2005-01-24 | 2006-07-27 | Japan Health Sciences Foundation | 心筋細胞への分化能を有する細胞 |
JP4734669B2 (ja) * | 2005-02-04 | 2011-07-27 | 独立行政法人産業技術総合研究所 | ヒト歯乳頭からの幹細胞及びその利用方法 |
JP2006230316A (ja) * | 2005-02-25 | 2006-09-07 | Japan Health Science Foundation | 瘢痕のない創傷治癒能を有する細胞およびその調製方法 |
AU2006202209B2 (en) * | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
JP2006194901A (ja) * | 2006-02-13 | 2006-07-27 | Hjl Inc | 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防 |
WO2007103442A1 (en) * | 2006-03-06 | 2007-09-13 | Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College | Biocompatible scaffolds and adipose-derived stem cells |
-
2008
- 2008-03-03 BR BRPI0807966-8A2A patent/BRPI0807966A2/pt not_active IP Right Cessation
- 2008-03-03 EP EP08726385A patent/EP2132299A4/en not_active Withdrawn
- 2008-03-03 SG SG2012014981A patent/SG179432A1/en unknown
- 2008-03-03 JP JP2009551758A patent/JP2010530214A/ja not_active Abandoned
- 2008-03-03 US US12/074,423 patent/US20080241113A1/en not_active Abandoned
- 2008-03-03 EP EP12172058A patent/EP2574665A1/en not_active Withdrawn
- 2008-03-03 TW TW097107382A patent/TW200902718A/zh unknown
- 2008-03-03 AU AU2008223426A patent/AU2008223426A1/en not_active Abandoned
- 2008-03-03 CA CA002679834A patent/CA2679834A1/en not_active Abandoned
- 2008-03-03 CN CN2012103225455A patent/CN102851254A/zh active Pending
- 2008-03-03 AR ARP080100886A patent/AR065584A1/es not_active Application Discontinuation
- 2008-03-03 WO PCT/US2008/002838 patent/WO2008109063A2/en active Application Filing
- 2008-03-03 CN CN200880014529A patent/CN101802171A/zh active Pending
- 2008-03-03 MX MX2009009414A patent/MX2009009414A/es active IP Right Grant
- 2008-03-03 KR KR1020097019844A patent/KR20090117817A/ko not_active Application Discontinuation
-
2009
- 2009-08-27 IL IL200620A patent/IL200620A0/en unknown
- 2009-08-31 CR CR11006A patent/CR11006A/es unknown
- 2009-09-01 HN HN2009001681A patent/HN2009001681A/es unknown
- 2009-09-01 SV SV2009003365A patent/SV2009003365A/es unknown
- 2009-11-10 US US12/615,372 patent/US20100040588A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HN2009001681A (es) | 2012-03-26 |
US20080241113A1 (en) | 2008-10-02 |
EP2132299A4 (en) | 2010-03-10 |
EP2574665A1 (en) | 2013-04-03 |
AR065584A1 (es) | 2009-06-17 |
WO2008109063A2 (en) | 2008-09-12 |
CN102851254A (zh) | 2013-01-02 |
CN101802171A (zh) | 2010-08-11 |
US20100040588A1 (en) | 2010-02-18 |
MX2009009414A (es) | 2009-11-02 |
JP2010530214A (ja) | 2010-09-09 |
CR11006A (es) | 2009-11-12 |
IL200620A0 (en) | 2011-08-01 |
AU2008223426A2 (en) | 2009-10-08 |
AU2008223426A1 (en) | 2008-09-12 |
SG179432A1 (en) | 2012-04-27 |
TW200902718A (en) | 2009-01-16 |
EP2132299A2 (en) | 2009-12-16 |
KR20090117817A (ko) | 2009-11-12 |
WO2008109063A3 (en) | 2008-12-11 |
CA2679834A1 (en) | 2008-09-12 |
BRPI0807966A2 (pt) | 2014-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2009003365A (es) | Obtencion, aislamiento y crioconservacion de celulas endometriales/menstruales ref. p1879 | |
EA201490050A1 (ru) | Композиции и способы повышения биоэнергетического состояния женских зародышевых клеток | |
CL2016003048A1 (es) | Analogos de panonina minimas sintesis y uso de los mismos. | |
CR20180175A (es) | Anticuerpos anti-cd19 humano con alta afinidad | |
PE20170188A1 (es) | Formulaciones y metodos de tratamiento con queratina | |
CL2008001984A1 (es) | Formulacion de anticuerpo anti-cd20; y su uso para tratar enfermedades que implican celulas que expresan cd20 en un mamifero. | |
BR112013004914A2 (pt) | "composições de pele e métodos de uso das mesmas". | |
CR20140185A (es) | Derivados de (4-fenilimidazol-2-il)etilamina útiles como moduladores de canal de sodio | |
CO6751287A2 (es) | Composición antigénetica de micobacteria | |
MY186535A (en) | Novel european prrsv strain | |
MX349554B (es) | Metodo para incrementar la actividad microbiana del suelo. | |
CO6541602A2 (es) | Composiciones orales que contienen extractos de zizyphus joazeiro y método relacionados | |
BR112014025458A8 (pt) | endoprótese de grande vaso desramificado e métodos para utilização | |
CO7210296A2 (es) | Derivados de alcohol graso insaturado de metátesis de aceite natural | |
AR091606A1 (es) | Composiciones orales de dentifrico y su uso en la fabricacion de un medicamento | |
BR112016013194A2 (pt) | Composições de higiene oral compreendendo carbonato de cálcio e sílica | |
BR112015029615A2 (pt) | uso cosmético, processo cosmético e composição | |
AR101236A1 (es) | Composiciones para el cuidado oral | |
AR100329A1 (es) | Composición y método para el cuidado oral | |
CL2008003282A1 (es) | Poblacion de celulas humanas que expresan cd34 las cuales son obtenidas a partir de expansion de celulas de sangre de cordon umbilical en presencia de celulas menstruales humanas, metodo para obtener dichas celulas. | |
BR112018015786A2 (pt) | rações animais que contêm glicolipídios específicos | |
AR098587A1 (es) | Sistema oxidante para composiciones para el cuidado oral | |
AR069958A1 (es) | Metodo para producir una proteina heterologa de interes | |
BR112013027775A2 (pt) | método de clareamento de pele | |
BR112013025582A2 (pt) | método e kit para remoção de pêlos |